Le Lézard
Classified in: Covid-19 virus
Subjects: Event, Webcast

Synovus Announces Change to a Virtual Meeting Format for 2020 Annual Meeting of Shareholders


Synovus Financial Corp. (NYSE: SNV) announced today that its 2020 Annual Meeting of Shareholders will be held in an online-only, virtual meeting format, due to the escalating nature of the coronavirus (COVID-19) pandemic and in the interest of public health, shareholders will not be able to attend the Annual Meeting in person. The previously announced date and time of the Annual Meeting ? Wednesday, April 22, 2020, at 10:00 a.m., Eastern Time ? has not changed.

Shareholders of record as of February 20, 2020, the record date, and those beneficial holders that hold a legal proxy or broker's proxy card for the Annual Meeting provided by their bank, broker, or nominee are entitled to attend and participate in the Annual Meeting. To attend and participate in the Annual Meeting, shareholders will need to go to www.virtualshareholdermeeting.com/SNV2020 and, when prompted, enter the 16-digit control number included in their proxy materials. Those without a 16-digit control number may attend the 2020 Annual Meeting as guests.

Further information regarding this change to a virtual meeting format only for the Annual Meeting can be found in the Notice of Change of Location of Annual Meeting of Shareholders filed by the Company with the Securities and Exchange Commission on April 8, 2020.

Synovus Financial Corp. is a financial services company based in Columbus, Georgia, with approximately $48 billion in assets. Synovus provides commercial and retail banking, investment, and mortgage services through 299 branches in Georgia, Alabama, South Carolina, Florida, and Tennessee. Synovus Bank, a wholly owned subsidiary of Synovus, has been recognized as one of the country's "Most Reputable Banks" by American Banker and the Reputation Institute. Synovus is on the web at synovus.com, and on Twitter, Facebook, LinkedIn, and Instagram.


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

28 mar 2024
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

28 mar 2024
Boat Rocker Media Inc. ("Boat Rocker" or the "Company") , an independent, integrated global entertainment company, today reported its financial results for the three months ended December 31, 2023 ("fourth quarter" or "Q4") and for the year ended...



News published on and distributed by: